tiprankstipranks
Trending News
More News >
Vor Biopharma (VOR)
NASDAQ:VOR
US Market
Advertisement

Vor Biopharma (VOR) Income Statement

Compare
931 Followers

Vor Biopharma Income Statement

Last quarter (Q3 2025), Vor Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vor Biopharma's net income was $-812.68M. See Vor Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.49M$ -8.96M$ 0.00$ 0.00
Operating Expenses
$ 121.19M$ 122.54M$ 84.46M$ 69.02M$ 43.37M
Depreciation and Amortization
$ 3.53M$ 3.49M$ 8.96M$ 1.43M$ 605.00K
EBITDA
$ -117.66M$ -114.37M$ -83.13M$ -67.58M$ -42.76M
Operating Income
$ -121.19M$ -126.04M$ -93.42M$ -69.02M$ -43.37M
Other Income/Expenses
$ 4.27M$ 8.17M$ 1.32M$ 119.00K$ 29.00K
Pretax Income
$ -116.91M$ -117.86M$ -92.09M$ -68.90M$ -43.34M
Net Income
$ -116.91M$ -117.86M$ -92.09M$ -68.90M$ -43.34M
Per Share Metrics
Basic EPS
$ -34.00$ -35.00$ -46.60$ -37.80$ -26.60
Diluted EPS
$ -34.00$ -35.00$ -46.60$ -37.80$ -26.60
Weighted Average Shares Outstanding
3.44M 3.36M 1.98M 1.86M 1.86M
Weighted Average Shares Outstanding (Diluted)
3.44M 3.36M 1.98M 1.86M 1.86M
Currency in USD

Vor Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis